Flutriciclamide ([18F]GE180), the third generation of TSPO tracer showed high signal in the inflammation site, low non-specific binding, and low radiometabolites signals in animal models of middle cerebral artery occlusion and AD. Here, TSPO is linked to Alzheimer disease.